Has Joshua Curtis received payments from drug or device companies?

Yes. Drug and device makers reported $1,364 in general payments to Joshua Curtis across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joshua Curtis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joshua Curtis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joshua Curtis

Nurse Practitioner · Blairsville, GANPI 1508415217

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $971 and has fallen 98.2% since, to $18 in 2025.

$1,364in general payments, 2019–2025

Across 72 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi-aventis U.S. LLC$200
Lilly USA, LLC$197
AstraZeneca$138
AbbVie$111
Pfizer$83
Novo Nordisk$80
plus $554 from 15 others

What the payments were for

Food & beverage$1,30596%
Gifts$594%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi-aventis U.S. LLC	12	$200
Lilly USA, LLC	13	$197
AstraZeneca	2	$138
AbbVie	5	$111
Pfizer	5	$83
Novo Nordisk	5	$80
Esperion Therapeutics, Inc.	5	$69
Teva Pharmaceuticals USA, Inc.	3	$62
Mannkind Corporation	1	$59
Takeda Pharmaceuticals U.S.A., Inc.	3	$51
Biohaven Pharmaceuticals, Inc.	3	$45
Otsuka America Pharmaceutical, Inc.	2	$41
Amgen(2 entities)	2	$37
Biohaven Pharmaceutical Holding Company Ltd.	2	$37
Genentech USA, Inc.	2	$35
GSK	2	$30
Paratek Pharmaceuticals, Inc.	1	$24
Siemens Medical Solutions USA, Inc.	1	$18
Daiichi Sankyo Inc.	1	$16
Merck	1	$16
Mylan Specialty L.p.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BREZTRI$125

How this compares

$1,364 in reported general payments places this provider in the 75th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia →

Other nurse practitioner in Blairsville

Jill NielsenBlairsville$38K
Victor CzerkasijDalton$505K
Kennon Mc CollumStockbridge$364K
Tajuana BradleyJohns Creek$256K
Jessica AdkinsSavannah$226K
Janice McAlisterAtlanta$221K
Laura ElledgeAtlanta$177K
Afsha HussainiKennesaw$122K
Elizabeth TyeAlbany$78K
Luis PoloSavannah$70K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →